Search

Many countries and regions have set up regulatory and policy frameworks to achieve sound chemicals and waste management. In addition to national and regional efforts, the international community has taken concerted joint actions to address specific issues of concern, including chemicals that can be transported over long distances by wind and water, are transported through global trade in resources, products and waste, or are used or are present in many countries.Substantial progress has been made by the international community, including

Chemicals are widely used in daily life. They have a unique importance in the health-care sector, where they are used as disinfectants, cleaners, laboratory re­agents, sterilants, pesticides, medicines and pharma­ceuticals and in medical devices and equipment. The hazards of these chemicals are not well understood by health professionals nor incorporated into procure­ment decisions.To minimize these hazards, the health sector has been taking steps to promote and implement sustainable healthcare within their institutions and to collaborate externally with suppliers and manufactures

This WHO technical report focuses on reviewing the risks to human health associated with exposure to trace concentrations of pharmaceuticals in drinking-water. Pharmaceuticals are synthetic or natural chemicals that can be found in prescription medicines, over-the-counter therapeutic drugs and veterinary drugs. Pharmaceuticals contain active ingredients that have been designed to have pharmacological effects and confer significant benefits to society. Traces of pharmaceuticals, typically at levels in the nanograms to low micrograms per litre range, have been reported in the water

Over the past decade a great amount of interest has arisen regarding the occurrence and fate of trace organic contaminants in the aquatic environment. Of particular concern are human hormones and pharmaceuticals, many of which are ubiquitous contaminants in conventional municipal wastewater treatment plant effluents when measured with ng/L detection limits. As analytical procedures and bioassay techniques become more readily available and increasingly sensitive, new contaminants will be discovered. The presence or absence of any chemical in a wastewater effluent

Endocrine disrupting compounds (EDCs) and pharmaceuticals and personal care products (PPCPs) are a group of chemical compounds with diverse physical and chemical properties. Recent studies have indicated undesired effects of EDCs and PPCPs at their reported trace concentrations. This paper reviews the current knowledge on the sources, properties, occurrence and health impacts of EDCs and PPCPs, and their removal from drinking water using ozonation and ozone/hydrogen peroxide-based advanced oxidation. The paper also examines the potential threats posed by these chemicals

Environmental contamination with pharmaceuticals is widespread, inducing risks to both human health and the environment. This paper explores potential societal solutions to human and veterinary pharmaceuticals in the aquatic environment. To this end, we adopt transition research’s multi-level perspective framework, which allows us to understand the dynamics underlying pharmaceutical emissions and to recognize social and technical factors triggering change. The authors' qualitative analysis is based on data collected through literature research and interviews with actors from pharmaceutical industry, the health

The environmental occurrence of antimicrobial pharmaceuticals and antibiotic resistant bacteria and antibiotic resistant genes has become a global phenomenon and a multifaceted threat. Integrated actions of many parties are needed to prevent further aggravation of the problem. Well-directed actions require clear understanding of the problem, which can be ensured by frequent revaluation of the existing knowledge and disseminating it among relevant audiences. The goal of this review paper is to discuss the occurrence and abundance of antimicrobial pharmaceuticals in the

The Summary for Policymakers - Environmental Dimensions of Antimicrobial Resistance (AMR) launched on the sidelines of UNEA 5.2 taking place from 28 February to 4 March 2022.The report calls to strengthen environmental action within the ‘One Health’ response to AMR, looks at the pollutants that exacerbate AMR in the environment, where they come from, and provides an overview of the environmental action required.

The healthcare sector has a unique healing mission, yet hospitals are key point sources for specialised pharmaceutical residues entering the environment, a serious source of pollution that can threaten ecosystems and the environment, as well as drive the development of antimicrobial resistance (AMR) – a serious public health threat.Up to 90% of orally administered pharmaceuticals are excreted into wastewater as active substances in the faeces and urine of patients. Wastewater treatment plants widely vary in their capacity to eliminate these

Management of Pharmaceutical Household Waste: Limiting Environmental Impacts of Unused or Expired MedicinePharmaceutical household waste from expired or unused medicine does not only offer zero therapeutic benefit, but also contributes to environmental pollution when disposed of via improper routes. Medicines discarded in sinks and flushed down toilets enter sewage waters and, if not filtered out, leak into aquatic systems. Disposal of unused or expired medicines via solid household waste can also result in pharmaceutical residues entering the environment if this